The SIB has become a benchmark assessment used extensively in worldwide clinical trials by drug companies seeking to develop treatments to combat Alzheimer's disease.
Why is the SIB valuable?
The SIB gathers direct performance-based data on a wide variety of low level tasks which take into account the specific behavioural and cognitive deficits associated with severe dementia.
This objective assessment of the relative impairment of different areas of cognitive functioning enhances our understanding of the disease process and provides valuable clinical information regarding the later stages of dementia.
The SIB evaluates cognitive abilities at the lower end of the range. The test was designed with the severely demented patient in mind. It is composed of simple one-step commands and gestural cues, and it allows for a variety of simple responses.
The SIB is designed to be psychometrically reliable and allows for repeated assessments. Each subscale yields scores to assess mild to moderate dementia.
The six major subscales are:
- visuo-spatial ability
In addition, there are also brief evaluations of praxis, social interaction and orienting to name.
Need further information?
Our Sales Consultants are available to provide product presentations, or attend team meetings, in-service study days or regional conferences. Find your nearest representative for advice on your assessment needs >